At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ITP IT Tech Packaging Inc
Post-Mkt 03-23 16:34:33 EDT
0.1815
+0.0053
+3.04%
盘后0.1815
+0.0000-0.03%
16:04 EDT
High0.1850Low0.1770Vol190.67K
Open0.1804D1 Closing0.1762Amplitude4.54%
Mkt Cap3.08MTradable Cap2.98MTotal Shares16.97M
T/O34.64KT/O Rate1.16%Tradable Shares16.42M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Press Release: Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Dow Jones  ·  30 minutes ago
Press Release: Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Argenx’s Long‑Term ITP Study Reaches Completion, Sharpening the Outlook for Efgartigimod
TIPRANKS  ·  03-17
Argenx’s Long‑Term ITP Study Reaches Completion, Sharpening the Outlook for Efgartigimod
Press Release: Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Dow Jones  ·  03-05
Press Release: Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
GlobeNewswire  ·  02-27
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
GlobeNewswire  ·  02-26
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire  ·  02-26
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies
GlobeNewswire  ·  02-24
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
GlobeNewswire  ·  02-09
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
Takeda’s Mezagitamab ITP Extension Study: Long-Term Data That Matters for Investors
TIPRANKS  ·  02-05
Takeda’s Mezagitamab ITP Extension Study: Long-Term Data That Matters for Investors
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
GlobeNewswire  ·  02-04
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
GlobeNewswire  ·  01-12
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
Press Release: Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
Dow Jones  ·  01-12
Press Release: Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
argenx Highlights 2026 Strategic Priorities
GlobeNewswire  ·  01-12
argenx Highlights 2026 Strategic Priorities
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
GlobeNewswire  ·  01-08
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
Hangzhou's "Six Little Dragons" See Another IPO Emerge
Deep News  ·  01-05
Hangzhou's "Six Little Dragons" See Another IPO Emerge
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
GlobeNewswire  ·  2025-12-15
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
GlobeNewswire  ·  2025-12-09
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
GlobeNewswire  ·  2025-12-03
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
GlobeNewswire  ·  2025-11-25
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Press Release: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
Dow Jones  ·  2025-11-14
Press Release: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Introduction

Company Name.
IT Tech Packaging Inc
Affiliated Markets:
AMEX
Listing Date:
--
Main Business:
IT Tech Packaging, Inc., together with its subsidiaries, engages in the production and distribution of paper products in the People's Republic of China. The company operates through three segments: Dongfang Paper, Tengsheng Paper, and Baoding Shengde. It offers corrugating medium papers to companies making corrugating cardboards; and offset printing papers to printing companies. The company also provides tissue paper products, including toilet papers, boxed and soft-packed tissues, handkerchief tissues, and paper napkins, as well as bathroom and kitchen paper towels under the Dongfang Paper brand. In addition, it produces and sells non-medical single-use face masks, and medical face masks. The company was formerly known as Orient Paper, Inc. and changed its name to IT Tech Packaging, Inc. in August 2018. The company is headquartered in Baoding, the People's' Republic of China.
Issue price:
--